Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for RVTY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -3.505M
March 31, 2026 -78.27M
December 31, 2025 -20.45M
September 30, 2025 18.97M
June 30, 2025 -9.493M
March 31, 2025 -6.378M
December 31, 2024 -17.33M
September 30, 2024 690.18M
June 30, 2024 121.49M
March 31, 2024 -18.18M
December 31, 2023 -414.81M
September 30, 2023 434.87M
June 30, 2023 -571.04M
March 31, 2023 1.865B
December 31, 2022 -25.68M
September 30, 2022 -22.51M
June 30, 2022 -28.36M
March 31, 2022 -56.31M
December 31, 2021 -59.95M
September 30, 2021 -3.301B
June 30, 2021 -290.02M
March 31, 2021 -461.85M
December 31, 2020 -436.40M
September 30, 2020 -22.52M
June 30, 2020 -23.56M
Date Value
March 31, 2020 -22.01M
December 31, 2019 -172.03M
September 30, 2019 -29.02M
June 30, 2019 -257.29M
March 31, 2019 -29.23M
December 31, 2018 -87.96M
September 30, 2018 8.019M
June 30, 2018 -56.25M
March 31, 2018 -23.67M
December 31, 2017 -1.454B
September 30, 2017 45.33M
June 30, 2017 271.82M
March 31, 2017 -129.84M
December 31, 2016 -22.65M
September 30, 2016 -70.43M
June 30, 2016 9.532M
March 31, 2016 -17.29M
December 31, 2015 -65.12M
September 30, 2015 -6.958M
June 30, 2015 -19.74M
March 31, 2015 -9.039M
December 31, 2014 -272.08M
September 30, 2014 -9.231M
June 30, 2014 -8.565M
March 31, 2014 -6.02M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. -1.032B
Thermo Fisher Scientific, Inc. 164.00M
Danaher Corp. -10.15B
Waters Corp. 2.00M
Bio-Rad Laboratories, Inc. -66.70M